-
Mashup Score: 1Impact of Interatrial Shunt May Vary by Heart Failure Type - American College of Cardiology - 1 month(s) ago
Contact: Nicole Napoli, nnapoli@acc.org, 202-669-1465 Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did not see any significant benefits overall compared with those who receive d a placebo procedure after a median of 22 months follow-up, in a study presented at the American College of Cardiology’s Annual Scientific Session. The trial, called RELIEVE-HF, is the first randomized placebo-procedure controlled trial of interatrial shunting that included
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes - 1 month(s) ago
Safia Chatur, MD, discusses the results of a PARADIGM-HF analysis at ACC.24 examining the effects of ARNI use across the updated 2024 KDIGO Risk Classifications.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Understanding Total Costs Associated with Hospitalization for Heart Failure, with Veraprapas Kittipibul, MD - 1 month(s) ago
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Understanding Total Costs Associated with Hospitalization for Heart Failure, with Veraprapas Kittipibul, MD - 1 month(s) ago
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Understanding Total Costs Associated with Hospitalization for Heart Failure, with Veraprapas Kittipibul, MD - 1 month(s) ago
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Impact of Interatrial Shunt May Vary by Heart Failure Type - American College of Cardiology - 1 month(s) ago
Contact: Nicole Napoli, nnapoli@acc.org, 202-669-1465 Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did not see any significant benefits overall compared with those who receive d a placebo procedure after a median of 22 months follow-up, in a study presented at the American College of Cardiology’s Annual Scientific Session. The trial, called RELIEVE-HF, is the first randomized placebo-procedure controlled trial of interatrial shunting that included
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 8RELIEVE-HF: Does Impact of Interatrial Shunting Differ By HF Type? - American College of Cardiology - 1 month(s) ago
Patients with heart failure (HF) who had an interatrial shunt inserted did not see any significant benefits overall, compared with those who underwent a placebo procedure, after a median 22-month follow-up, but results suggest the benefits of an interatrial shunt may vary by HF type, according to results from the RELIEVE-HF study presented during a Late-Breaking Clinical Trial session at ACC.24. The first placebo-procedure controlled trial of interatrial shunting (with the Ventura shunt) in patients with
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 18A Double-Blind, Randomized Placebo-Procedure-Controlled Trial of an Interatrial Shunt in Patients With HFrEF and HFpEF - American College of Cardiology - 1 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2
People who use e-cigarettes are significantly more likely to develop heart failure than nonusers, according to one of the largest prospective studies to date in this area.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
People who use e-cigarettes are significantly more likely to develop #heartfailure than nonusers, according to one of the largest prospective studies to date in this area. The findings are being presented at #ACC24 @ACCinTouch @yakoubenehasan Read More: https://t.co/WvoRW3bM2V https://t.co/AOZkkaWzrF
-
First randomized placebo-procedure controlled trial shows signals that the benefits and risks of interatrial shunts may vary by #HeartFailure type, according to a new study presented by @GreggWStone at #ACC24. @IcahnMountSinai https://t.co/UpdWedZpdL https://t.co/yWQ2CXtgmr